Fifty410 Pricing in 2026: Medication, Membership and Total Monthly

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Fifty410 charges $199 per month for compounded semaglutide injection billed monthly, with no membership or service fee. For tirzepatide, Fifty410 uses a three-month prepaid model with three dose tiers: $399 upfront for the starter tier ($133/month prepaid equivalent), $499 upfront for mid-dose ($166/month prepaid equivalent), and $549 upfront for high-dose ($183/month prepaid equivalent). All programs include the consult, medication, and shipping; semaglutide has no subscription contract, while tirzepatide ships the full three-month supply at once. Over twelve months, Fifty410 semaglutide costs $2,388, and tirzepatide costs $1,596–$2,188 depending on tier—but those tirzepatide figures assume you stay in one tier for the full year, and dose progression may move you between tiers.

Fifty410 pricing at a glance

Pricing captured September 4, 2026. Twelve-month totals for tirzepatide assume you remain in the same tier for four three-month cycles; dose adjustments may move you between tiers.

Breaking down Fifty410's billing structure

Semaglutide: straightforward monthly billing

Fifty410 charges $199 per month for compounded semaglutide injection, billed monthly with no subscription contract. You pay only if the provider writes the prescription, and the $199 covers the consult, medication, and shipping. There is no separate membership or service fee. Over twelve months, the total is $2,388—our calculation, $199 × 12.

Tirzepatide: three-month upfront payment, three dose tiers

Fifty410's tirzepatide program requires upfront payment for a three-month supply, shipped at once. Three tiers correspond to dose ranges:

• Starter tier: $399 upfront for three months ($133/month prepaid equivalent)
• Mid-dose tier: $499 upfront for three months ($166/month prepaid equivalent)
• High-dose tier: $549 upfront for three months ($183/month prepaid equivalent)

The tier you pay depends on the dose your provider prescribes. If your dose increases mid-program and crosses into a higher tier, the next three-month payment reflects that tier's rate. Each payment covers the consult, medication, and shipping; there is no separate membership fee.

Calculating the twelve-month cost requires assuming you stay in one tier for all four three-month cycles:

• Starter tier: $399 × 4 = $1,596 first year ($133/month average, our calculation)
• Mid-dose tier: $499 × 4 = $1,996 first year ($166/month average, our calculation)
• High-dose tier: $549 × 4 = $2,188 first year ($183/month average, our calculation)

In practice, many patients titrate upward, so your effective annual cost may blend tiers. Fifty410's provider portal captured September 4, 2026 does not specify the exact dose cutoffs for each tier, so you will learn your tier assignment after the initial consultation.

Comparing Fifty410 and PlexusDx: month-to-month vs upfront commitment

Semaglutide: PlexusDx $10/month lower, month-to-month

PlexusDx charges $189 per month for compounded semaglutide injection on a month-to-month basis, $10/month less than Fifty410's $199. Over twelve months:

• PlexusDx: $189 × 12 = $2,268 (our calculation)
• Fifty410: $199 × 12 = $2,388 (our calculation)
• Difference: $120 first year in PlexusDx's favor

Both programs include consult, medication, and shipping with no membership fee. PlexusDx also offers multi-month prepaid plans—$169/month on a three-month plan and $149/month on a six-month plan—which widen the gap if you are willing to commit upfront.

Tirzepatide: Fifty410's starter tier lower, PlexusDx simpler and dose-agnostic

Comparing tirzepatide requires matching billing structure. Fifty410's three-month prepaid tiers vs PlexusDx's three-month plan ($269/month, $807 upfront every three months):

Fifty410's starter tier is $1,632 less over twelve months than PlexusDx's three-month plan (our calculation). Even Fifty410's high-dose tier ($2,188/year) is $1,040 less than PlexusDx's three-month rate.

The trade-off: Fifty410's price depends on your dose tier, and moving between tiers as your dose increases changes your quarterly payment. PlexusDx charges one flat rate at every dose—$289/month month-to-month or $269/month on the three-month plan—so your cost is predictable regardless of titration. PlexusDx also offers a month-to-month option ($289) with no upfront commitment; Fifty410's tirzepatide requires the three-month upfront payment from the start.

What's included and what costs extra

Both Fifty410 and PlexusDx bundle the provider consult, prescription, compounded medication, and shipping into the advertised price. Neither charges a separate membership, platform, or service fee. You pay the medication price and nothing else—assuming the provider writes the prescription.

Fifty410's semaglutide program has no subscription contract; you can pause or stop without penalty. Tirzepatide ships the full three-month supply upfront, so you are committing to that quarter's payment when you order, but there is no indication of an ongoing subscription obligation beyond the three-month cycle you prepay.

Regulatory status and medication sourcing

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Fifty410 works with compounding pharmacies to supply semaglutide and tirzepatide injections. PlexusDx works with licensed 503A compounding pharmacies. Neither provider's compounded products are FDA-approved or interchangeable with branded Wegovy, Ozempic, Mounjaro, or Zepbound.

Service quality and user experience

Fifty410's provider page displays a 4.8-star Trustpilot rating with 5,891 reviews, captured September 4, 2026. The research pass did not capture negative theme excerpts from Trustpilot or Reddit, so we cannot report specific complaint patterns here. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher, captured September 9, 2026.

Fifty410's tirzepatide tiers introduce a layer of complexity: you learn your tier after the consultation, and dose increases may move you to a higher tier and a higher quarterly payment. Some patients prefer knowing the exact cost upfront; others accept tier-based pricing in exchange for the lower entry price. PlexusDx's flat-rate-at-every-dose model eliminates that uncertainty.

Choose Fifty410 if…

• You are starting tirzepatide and expect to stay in a lower dose range for several months—the $399 starter tier offers a meaningful cost advantage over flat-rate competitors.
• You are comfortable with three-month upfront payments and tier-based pricing, understanding that your quarterly cost may increase if your dose rises.
• You want semaglutide with no subscription contract and are willing to pay $199/month ($10/month more than PlexusDx) for the flexibility of Fifty410's provider network or service model.
• The 4.8-star Trustpilot rating and large review volume give you confidence in service quality.

Choose PlexusDx if…

• You want predictable pricing regardless of dose—one flat rate for semaglutide ($189/month to $149/month depending on commitment) and one flat rate for tirzepatide ($289/month to $249/month) at every milligram.
• You prefer month-to-month flexibility with no upfront payment—PlexusDx offers true month-to-month billing for both semaglutide and tirzepatide; Fifty410 requires three-month upfront for tirzepatide.
• You are choosing semaglutide and want the lowest ongoing rate—PlexusDx is $10/month less than Fifty410 on month-to-month and $50/month less on the six-month plan.
• You value transparent cost structure from day one, with no tier surprises as your dose adjusts.

Methodology and freshness

Fifty410 pricing was captured from the provider's public pricing page and help center on September 4, 2026. PlexusDx pricing reflects live product pages captured between July 17 and July 23, 2026, confirmed current as of September 7, 2026. All twelve-month totals and per-month prepaid equivalents are our calculations, derived by multiplying the verified per-cycle price by the appropriate number of cycles. Trustpilot ratings and review counts were captured September 4, 2026 from provider pages; no individual review text is excerpted here. We confirmed that an older Fifty410 help-center page showed different tirzepatide tiers; the current pricing page figures are used throughout this article, and any reader seeing different numbers at checkout should verify with Fifty410 directly. No promotional codes or introductory discounts were observed or reported.

Frequently Asked Questions

Does Fifty410 charge a membership fee?

No. Fifty410 includes the consult, medication, and shipping in the medication price with no separate membership, platform, or service fee for either semaglutide or tirzepatide programs.

How does Fifty410's tirzepatide tier pricing work?

Fifty410 assigns you to a starter, mid-dose, or high-dose tier based on the dose your provider prescribes. You pay the corresponding upfront amount for three months of medication. If your dose increases and crosses into a higher tier, your next three-month payment reflects the new tier rate.

Can I pay month-to-month for tirzepatide with Fifty410?

No. Fifty410's tirzepatide program requires a three-month upfront payment, and the full three-month supply ships at once. Semaglutide is billed monthly with no upfront commitment. PlexusDx offers true month-to-month billing for both semaglutide and tirzepatide.

How much do I save with Fifty410's tirzepatide starter tier over twelve months?

If you remain in Fifty410's starter tier for all four three-month cycles, you pay $1,596 over twelve months—our calculation, $399 × 4. Compared to PlexusDx's three-month tirzepatide plan at $3,228/year, that is $1,632 less, but the savings disappear if dose increases move you into higher tiers.

Is Fifty410's compounded semaglutide interchangeable with Wegovy?

No. Compounded semaglutide is not FDA-approved and is not interchangeable with branded Wegovy or Ozempic. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a compounded prescription is appropriate for you.

Sources

• Fifty410 pricing page, captured September 4, 2026 13:49:55 UTC
• Fifty410 help center, captured September 4, 2026 13:49:55 UTC
• PlexusDx product pages (semaglutide injection, tirzepatide injection), captured July 17–23, 2026, confirmed current September 7, 2026
• Trustpilot provider pages (Fifty410, PlexusDx), captured September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.